SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-030099
Filing Date
2022-11-01
Accepted
2022-11-01 16:30:19
Documents
13
Period of Report
2022-11-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38332
2 ex99-1.htm EX-99.1 16129
  Complete submission text file 0001493152-22-030099.txt   231344

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sonn-20221101.xsd EX-101.SCH 3230
4 XBRL LABEL FILE sonn-20221101_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE sonn-20221101_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3616
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 221350844
SIC: 2834 Pharmaceutical Preparations